HepVu News & Updates
Stay up to date with new data, maps, infographics, blog posts, and other educational resources to help you better understand the Hepatitis B and Hepatitis C epidemics in the U.S. and their intersection with the opioid epidemic.
Vu Q&A: APIAHF on HIV and Viral Hepatitis in the AANHPI Community
Vu spoke with the Capacity for Health team at the Asian and Pacific Islander American Health Forum on HIV, viral hepatitis, and health inequities among the Asian American, Native Hawaiian, and Pacific Islander community in the U.S.
Read More
Visualizing Hepatitis C Treatment Restrictions
On May 19, at 3pm ET, HepVu hosted a webinar to discuss treatment restrictions as barriers to Hepatitis C care, trends over time, how to advocate for eliminating these restrictions, and prime examples of how these restrictions harm people living with Hepatitis C. Moderator: Heather Bradley, PhD, Assistant Professor of Epidemiology, Georgia State University Panelists:
Read More
Hepatitis C Treatment Restrictions
Hepatitis C treatment restrictions in Medicaid have become less severe over the last decade since the introduction of direct-acting antivirals (DAAs). Fewer treatment restrictions allow for increased access to Hepatitis C treatment for patients in Medicaid programs.
Read More
Patient Perspective on the Challenges of Treatment Restrictions in Hepatitis C Care
HepVu sat down with Paul Kelly to discuss his personal story, and the challenges he faced in accessing Hepatitis C care due to treatment restrictions.
Read More
Dr. Lesley Miller on the Impact of Hepatitis C Treatment Restrictions on Patient Care
HepVu interviewed Lesley Miller, MD, Professor in Emory University School of Medicine’s Division of General Internal Medicine and Medical Director of the Grady Liver Clinic at Grady Memorial Hospital about treatment restrictions from the view of a Hepatitis C care provider.
Read More
CHLPI and NVHR on the State of Hepatitis C Treatment Restrictions
HepVu sat down with Daniel Raymond of the National Viral Hepatitis Roundtable (NVHR) and Phil Waters of the Center for Health Law and Policy Innovation (CHLPI) at Harvard Law School to discuss the history and current landscape of treatment restrictions in the U.S.
Read MoreUpcoming Events
Get involved and learn more by attending conferences, webinars, and other events to help you better understand the viral hepatitis epidemic in the U.S. Have an upcoming viral hepatitis-related event? Email us at info@hepvu.org.
The True Cost of Discriminatory Hepatitis B Drug Tiering
Philadelphia FIGHT Community Health Centers is hosting a webinar on their analysis of adverse tiering practices for Hepatitis B treatments in Pennsylvania and underscore the importance of equitable access to treatment and services.
Learn More
HARM: Hepatitis, Addiction & Stigma Reduction in Medicine
Project ECHO presents HARM: Hepatitis, Addiction & Stigma Reduction in Medicine, an interactive series addressing the syndemic of Opioids and Hepatitis in America, with a focus on drug use, hepatitis C, and Harm Reduction.
Learn More
NPHL Public Health Law Conference
At this critical moment for public health in the United States, come together with others to learn how the strategic use of legal and policy tools can address fundamental drivers of inequity, promote health and well-being, and save lives.
Learn MoreBeyond the Map
Learn more about the Hepatitis B and Hepatitis C epidemics in the U.S.
Deeper Look: Opioids
Take a deeper look at how the ongoing opioid crisis impacts the Hepatitis C epidemic in the U.S.
Learn MoreView Local Data
Learn more about Hepatitis C where you live with state-specific statistics and national and regional comparison charts.
Learn MoreHepatitis ABCs
Know the difference between Hepatitis A, B, and C? Learn the facts, symptoms, and who’s at risk for each disease here.
Learn More
